Herbert Irving Cancer Center — New York, New York

Herbert Irving Cancer Center is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Herbert Irving Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Soft Tissue Sarcoma, Prostate Cancer.

Sponsors: Synta Pharmaceuticals Corp., Xanthus Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Herbert Irving Cancer Center?

Herbert Irving Cancer Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Herbert Irving Cancer Center conducted?

Herbert Irving Cancer Center has 2 clinical trials on record. Their work covers Soft Tissue Sarcoma, Prostate Cancer.

Is Herbert Irving Cancer Center accredited by Crixeo Health?

Herbert Irving Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Herbert Irving Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.